Aspira Women's Health (AWHL) corrects CFO stock option award terms

Rhea-AI Filing Summary

Aspira Women's Health Inc. reported that Chief Financial Officer John Strahley received a corrected grant of 70,000 employee stock options to buy common stock at an exercise price of $0.50 per share, expiring June 16, 2036. 17,500 options vest on July 26, 2026, with the remaining shares vesting in equal monthly installments over the following nine months.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Strahley John

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy) F1, F2	70,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 70,000 shares (Direct)

Footnotes (2)

1. F1. This form is being filed to correct the number of options awarded.
2. F2. 17,500 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.

Key Figures

Stock options granted: 70,000 options Exercise price: $0.50 per share Expiration date: June 16, 2036 +2 more

5 metrics

Stock options granted 70,000 options Employee stock options granted to CFO John Strahley on 2026-06-16

Exercise price $0.50 per share Conversion or exercise price of the reported employee stock options

Expiration date June 16, 2036 Expiration of the 70,000 employee stock options granted

Initial vesting tranche 17,500 options Portion of options vesting on July 26, 2026

Remaining vesting amount 52,500 options Options vesting in equal monthly installments over the next nine months after July 26, 2026

Key Terms

Employee Stock Option (Right to Buy), exercise price, vest in equal monthly installments

3 terms

Employee Stock Option (Right to Buy) financial

"security_title: Employee Stock Option (Right to Buy) for 70,000 shares"

exercise price financial

"conversion_or_exercise_price: 0.5000 indicates the option exercise price per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in equal monthly installments financial

"The remaining shares will vest in equal monthly installments over the next 9 months."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 06:33 PM Accepted by SEC EDGAR 07/17/2026 - 06:33 PM Learn about SEC filing dates

FAQ

What did Aspira Women's Health (AWHL) disclose about CFO John Strahley in this Form 4/A?

Aspira Women's Health reported that Chief Financial Officer John Strahley received a corrected grant of 70,000 employee stock options at an exercise price of $0.50 per share, expiring June 16, 2036, with vesting starting July 26, 2026 and continuing monthly for nine months.

How many stock options were granted to Aspira Women's Health (AWHL) CFO John Strahley?

CFO John Strahley was granted 70,000 employee stock options linked to Aspira Women's Health common stock. Following this grant, his reported derivative holdings from this award total 70,000 options, all held directly, subject to the stated vesting schedule through 2027.

What are the exercise price and expiration date of John Strahley’s AWHL stock options?

The options granted to CFO John Strahley carry an exercise price of $0.50 per share and an expiration date of June 16, 2036. These terms apply to all 70,000 options reported in this Form 4/A amendment.

How do the AWHL stock options granted to CFO John Strahley vest?

The grant’s vesting schedule provides that 17,500 options vest on July 26, 2026. The remaining 52,500 options then vest in equal monthly installments over the next nine months, resulting in full vesting within that period.

Why was this Aspira Women's Health (AWHL) Form 4/A amendment filed?

The amendment was filed because the company stated that the form is being filed to correct the number of options awarded. It updates the previously reported grant so that it now reflects the corrected figure of 70,000 stock options.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strahley John

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC.

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/15/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$0.5	06/16/2026		A		70,000(1)		(2)	06/16/2036	Common Stock	70,000	$0	70,000	D

Explanation of Responses:

1. This form is being filed to correct the number of options awarded.

2. 17,500 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months.

	/s/ John Strahley	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)